https://orcid.org/0000-0002-1813-7625
References
- Abd El Latif E, Abdelhalim AS, Montasser AS, et al. Pattern of intermediate uveitis in an Egyptian cohort. Ocul Immunol Inflamm. 2019;00(00):1–8. doi:10.1080/09273948.2019.1668429.
- Zein G, Berta A, Foster S. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12(2):137–142. doi:10.1080/09273940490895344.
- Niederer RL, Sharief LA, Bar A, Lightman SL, Tomkins-Netzer O. Predictors of long-term visual outcome in intermediate uveitis. Ophthalmol. 2017;124(3):393–398. doi:10.1016/j.ophtha.2016.11.013.
- Messenger W, Hildebrandt L, Mackensen F, Suhler E, Becker M, Rosenbaum JT. Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol. 2015;99(2):205–209. doi:10.1136/bjophthalmol-2014-305518.
- Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9(2):93–102. doi:10.1076/ocii.9.2.93.3975.